Jane Street Group, LLC Mersana Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 17, 2021
BUY
$16.84 - $27.59 $3.47 Million - $5.69 Million
206,300 Added 787.4%
232,500 $6.19 Million
Q3 2020

Nov 17, 2020
SELL
$16.2 - $25.7 $2.03 Million - $3.22 Million
-125,200 Reduced 82.69%
26,200 $488,000
Q2 2020

Aug 17, 2020
BUY
$5.24 - $23.4 $793,336 - $3.54 Million
151,400 New
151,400 $3.54 Million

Others Institutions Holding MRSN

# of Institutions
123
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $60.2M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email